Page 1064 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1064

References    11


                   302. Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ,       319. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A com-
                      Verweij PE. Bifidobacterium lipoteichoic acid and false   parison of vancomycin and metronidazole for the treatment of
                      ELISA  reactivity  in aspergillus antigen detection.  Lancet.   Clostridium difficile-associated diarrhea, stratified by disease
                      2004;363(9405):325-327.                                severity. Clin Infect Dis. 2007;45(3):302-307.
                   303. Naaber P, Smidt I, Tamme K, et al. Translocation of indigenous     320. Bartlett JG. Management of Clostridium difficile infection
                      microflora in an experimental model of sepsis. J Med Microbiol.   and other antibiotic-associated diarrhoeas. Eur J Gastroenterol
                      2000;49(5):431-439.                                    Hepatol. 1997;8:1054-1061.
                   304. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E.      321. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluo-
                      Treatment with piperacillin-tazobactam and false-positive   roquinolones as the predominant risk factor for Clostridium
                      Aspergillus galactomannan antigen test results for patients with   difficile-associated diarrhea: a cohort study during an epidemic
                      hematological malignancies. Clin Infect Dis. 2004;38(6):917-920.  in Quebec. Clin Infect Dis. 2005;41(9):1254-1260.
                   305. Viscoli C, Machetti M, Cappellano P, et al. False-positive galac-    322. Husain A, Aptaker L, Spriggs DR, Barakat RR. Gastrointestinal
                      tomannan platelia Aspergillus test results for patients receiving   toxicity and Clostridium difficile diarrhea in patients treated
                      piperacillin-tazobactam. Clin Infect Dis. 2004;38(6):913-916.  with paclitaxel-containing chemotherapy regimens.  Gynecol
                   306. Sulahian A, Touratier S, Ribaud P. False positive test for aspergil-  Oncol. 1998;71(1):104-107.
                      lus antigenemia related to concomitant administration of piper-    323. Bilgrami S, Feingold JM, Dorsky D, et al. Incidence and
                      acillin and tazobactam. N Engl J Med. 2003;349(24):2366-2367.  outcome of Clostridium difficile infection following autolo-
                   307. Mikulska M, Furfaro E, Del Bono V, et al. Piperacillin/   gous peripheral blood stem cell transplantation. Bone Marrow
                      tazobactam (Tazocin) seems to be no longer responsible for   Transplant. 1999;23(10):1039-1042.
                      false-positive results of the galactomannan assay. J Antimicrob     324. Tomblyn M, Gordon L, Singhal S, et al. Rarity of toxigenic
                      Chemother. July 2012;67(7):1746-1748.                  Clostridium  difficile  infections  after  hematopoietic  stem  cell
                   308. Cornelissen JJ, Rozenberg-Arska M, Dekker AW. Discontinuation   transplantation: implications for symptomatic management of
                      of intravenous antibiotic therapy during persistent neutropenia   diarrhea. Bone Marrow Transplant. 2002;30(8):517-519.
                      in patients receiving prophylaxis with oral ciprofloxacin. Clin     325. Simor  AE.  Diagnosis,  management,  and  prevention  of
                      Infect Dis. 1995;21:1300-1302.                         Clostridium difficile infection in long-term care facilities: a
                   309. Rubin RH. Empiric antibacterial therapy in granulocyto-  review. J Am Geriatr Soc. August 2010;58(8):1556-1564.
                      penia induced by cancer chemotherapy.  Ann Intern Med.     326. Kunkel JM, Rosenthal D. Management of the ileoce-
                      1988;108(1):134-136.                                   cal syndrome. Neutropenic enterocolitis.  Dis Colon Rectum.
                                                                             1986;29(3):196-199.
                   310. Overholser CD, Peterson DE, Williams LT, Schimpff SC.
                      Periodontal infection in patients with acute nonlymphocyte     327. Moir CR, Scudamore CH, Benny WB. Typhlitis: selective
                      leukemia: prevalence of acute exacerbations. Arch Intern Med.     surgical management. Am J Surg. 1986;151(5):563-566.
                      1982;142(3):551-554.                                 328. Keidan RD, Fanning J, Gatenby RA, Weese JL. Recurrent
                   311. DeGregorio MW, Lee WM, Ries CA. Candida  infections in     typhlitis: a disease resulting from aggressive chemotherapy. Dis
                      patients with acute leukemia: ineffectiveness of nystatin pro-  Colon Rectum. 1989;32(3):206-209.
                      phylaxis and relationship between oropharyngeal and systemic     329. Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH. The
                      candidiasis. Cancer. 1982;50:2780-2784.                medical and surgical management of typhlitis in children
                   312. Montgomery MT, Redding SW, LeMaistre CF. The incidence   with acute nonlymphocytic (myelogenous) leukemia.  Cancer.
                      of oral herpes simplex virus infection in patients undergo-  1986;57(3):603-609.
                      ing cancer chemotherapy.  Oral Surg Oral Med Oral Pathol.     330. Gomez L, Martino R, Rolston KV. Neutropenic enterocolitis:
                      1986;61(3):238-242.                                    spectrum of the disease and comparison of definite and possible
                   313. Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE,   cases. Clin Infect Dis. 1998;27:695-699.
                      Meyers JD. Intravenous acyclovir to treat mucocutaneous     331. Kasper K, Loewen R, Bow E. Neutropenic enterocolitis (NEC)
                      herpes simplex virus infection after marrow transplantation: a   in adult leukemia (AL) patients (pts) in Manitoba. Clin Infect
                      double-blind trial. Ann Intern Med. 1982;96(3):265-269.  Dis. 1996;23(2):866.
                   314. Lindquist SF, Hickey AJ, Drane JB. Effect of oral hygiene on     332. Cartoni C, Dragoni F, Micozzi A, et al. Neutropenic enteroco-
                      stomatitis in patients receiving cancer chemotherapy. J Prosthet   litis in patients with acute leukemia: prognostic significance
                      Dent. 1978;40(3):312-314.                              of bowel wall thickening detected by ultrasonography.  J Clin
                   315. Peterson DE, Minah GE, Overholser CD, et al. Microbiology of   Oncol. 2001;19(3):756-761.
                      acute periodontal infection in myelosuppressed cancer patients.     333. Girmenia C, Micozzi A, Cartoni C, De Bernardis F, Cassone A,
                      J Clin Oncol. 1987;5(9):1461-1468.                     Martino P. Detection of Candida mannoproteinemia in patients
                   316. Gold D, Corey L. Acyclovir prophylaxis for herpes simplex virus   with neutropenic enterocolitis. Eur J Clin Microbiol Infect Dis.
                      infection. Antimicrob Agents Chemother. 1987;31(3):361-367.  1999;18(1):55-58.
                   317. Ferretti GA, Ash RC, Brown AT, Parr MD, Romond EH, Lillich TT.     334. Glenn J, Cotton D, Wesley R, Pizzo P. Anorectal infections in
                      Control of oral mucositis and candidiasis in marrow transplanta-  patients with malignant disease. Rev Infect Dis. 1988;10(1):42-52.
                      tion: a prospective, double-blind trial of chlorhexidine digluco-    335. Cohen JS, Paz IB, O’Donnell MR, Ellenhorn JD. Treatment of
                      nate oral rinse. Bone Marrow Transplant. 1988;3(5):483-493.  perianal infection following bone marrow transplantation. Dis
                   318. Brammer KW. Management of fungal infection in neutro-  Colon Rectum. 1996;39(9):981-985.
                      penic  patients  with  fluconazole.  Haematol  Blood  Transfus.     336. Bodey GP. Unusual presentations of infection in neutropenic
                      1990;33:546-550.                                       patients. Int J Antimicrob Agents. 2000;16(2):93-95.








          Section05-O-ref.indd   11                                                                                  1/20/2015   4:51:20 PM
   1059   1060   1061   1062   1063   1064   1065   1066   1067   1068   1069